ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
European Stroke Organisation shared on LinkedIn:
”ESOC 2026 recordings are now available on eSTEP!
Watch a preview on our YouTube channel with a featured playlist on Cerebral Amyloid Angiopathy (CAA).
ESO members can now access the full library of recorded sessions on eSTEP, the European Stroke Organisation’s dedicated online education platform.
This session brings together leading clinicians and researchers to discuss some of the most important developments in CAA, including neuroinflammation and emerging biomarker frameworks, CAA-related transient focal neurological episodes, the role of CAA in acute stroke reperfusion therapies, the relationship between CAA-related inflammation and ARIA, and new evidence on iatrogenic CAA.
The session provides valuable insights into current diagnostic challenges, treatment considerations, and the evolving understanding of CAA and its clinical implications for stroke care.
Access the full ESOC 2026 recording library on eSTEP.
Not an ESO member yet?
Join ESO today to gain access to eSTEP and many other educational resources.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 12:56Registration Is Now Open for ASH 2026
-
Aug 13, 2026, 12:48Annie Bauzon: Understanding the Genetics of Hemophilia
-
Aug 13, 2026, 11:15Bridging Neurology and Thrombosis: Key Priorities from a New Expert Consensus Report – International Journal of Stroke
-
Aug 13, 2026, 11:05Khaled Musallam: The Evolving Landscape of β-Thalassemia: Clinical Trial Advances Since 2021
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?